% | $
Quotes you view appear here for quick access.

Alnylam Pharmaceuticals, Inc. Message Board

  • pumptracker pumptracker Aug 9, 2012 9:00 AM Flag

    Co-Founder has Liquidated

    The two scientists at the center of the University of Utah’s lawsuit against Alnylam over patented RNA inference technologies are among the world’s top RNA researchers.

    Thomas Tuschl, who heads the Laboratory for RNA Molecular Biology at Rockefeller University in New York City is a co-founder of Cambridge-based Alynlam Pharmaceuticals has recently liquidated all his holdings within the company.

67.57-3.00(-4.25%)May 27 4:00 PMEDT